Atossa Therapeutics

-$0.0293 (-3.33%) Today
-$0.0009 (-0.11%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.

CEO
Steven C. Quay
Employees
8
Headquarters
Seattle, Washington
Founded
2008

ATOS Key Statistics

Market cap
107.77M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.19M
High today
$0.8989
Low today
$0.836
Open price
$0.89
Volume
1.65M
52 Week high
$9.80
52 Week low
$0.836

ATOS Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure